SANGUEDOLCE, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 3.381
NA - Nord America 2.567
AS - Asia 1.073
SA - Sud America 16
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
AF - Africa 9
Totale 7.068
Nazione #
US - Stati Uniti d'America 2.559
IE - Irlanda 1.371
CN - Cina 728
SE - Svezia 638
UA - Ucraina 520
IT - Italia 348
SG - Singapore 175
FR - Francia 130
FI - Finlandia 96
DE - Germania 94
IN - India 91
GB - Regno Unito 63
TR - Turchia 59
CZ - Repubblica Ceca 37
ES - Italia 13
GR - Grecia 11
AT - Austria 10
AU - Australia 10
EU - Europa 10
BE - Belgio 9
RU - Federazione Russa 9
CL - Cile 8
NL - Olanda 8
BR - Brasile 5
CA - Canada 5
IR - Iran 5
JP - Giappone 5
PL - Polonia 5
VN - Vietnam 4
ZA - Sudafrica 4
CH - Svizzera 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
DK - Danimarca 2
HU - Ungheria 2
IL - Israele 2
KE - Kenya 2
MG - Madagascar 2
MK - Macedonia 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AZ - Azerbaigian 1
EG - Egitto 1
KH - Cambogia 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
PA - Panama 1
PK - Pakistan 1
Totale 7.068
Città #
Dublin 1.371
Chandler 486
Nyköping 480
Jacksonville 357
Dearborn 222
New York 183
Nanjing 164
Princeton 141
Singapore 129
Ashburn 98
Wilmington 90
Nanchang 78
Beijing 70
Helsinki 54
San Mateo 51
Shenyang 51
Munich 45
Ann Arbor 39
Boardman 37
Los Angeles 37
Rome 36
Tianjin 28
Foggia 27
Hebei 27
Brno 24
Bari 23
Jiaxing 23
Kunming 23
Milan 23
Jinan 22
Pune 22
Shanghai 22
Guangzhou 19
Des Moines 18
Hangzhou 18
Changsha 16
Olomouc 13
Seattle 12
Reading 11
Taizhou 10
Washington 10
Zhengzhou 10
Brussels 9
London 9
Ningbo 9
Norwalk 9
Borås 8
Redwood City 8
Woodbridge 8
Wuhan 8
Changchun 7
Marousi 7
Orange 7
Chengdu 6
Fuzhou 6
Chicago 5
Clearwater 5
Genoa 5
Hobart 5
Madrid 5
Naples 5
Pescara 5
Santa Clara 5
Voghera 5
Xi'an 5
Florence 4
Hanover 4
Lavagna 4
Paris 4
Villasanta 4
Andria 3
Bitonto 3
Casalgrande 3
Dalian 3
Houston 3
Isola del Liri 3
Jinhua 3
Leawood 3
Nantong 3
Novokuznetsk 3
Quanzhou 3
Rui'an 3
San Jose 3
San Severo 3
Santa Cruz de Tenerife 3
Shenzhen 3
Slough 3
Strasbourg 3
Tehran 3
Tokyo 3
Treviolo 3
Valencia 3
Vienna 3
Xuzhou 3
Ariccia 2
Asiago 2
Athens 2
Austin 2
Banja Luka 2
Bisceglie 2
Totale 4.875
Nome #
Bioptic prostatic inflammation correlates with false positive rates of multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer 158
Post-void residual urinary volume is an independent predictor of biopsy results in men at risk for prostate cancer 133
A recurrent epidermoid cyst of the spleen: report of a case and literature review 119
Un caso di sarcoma di Kaposi viscerale in un paziente con morbo di crohn duodenale e immunodeficienza congenita. 107
PSA Density Help to Identify Patients With Elevated PSA Due to Prostate Cancer Rather Than Intraprostatic Inflammation: A Prospective Single Center Study 101
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 100
Urinary RKIP/p-RKIP is a potential diagnostic and prognostic marker of clear cell renal cell carcinoma 99
Cyclooxygenase isozymes 1 and 2 in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations 94
Absence of bladder outlet obstruction is an independent risk factor for prostate cancer in men undergoing prostate biopsy 93
Epigenetic inactivation of the WNT-pathway genes in oral squamous cell carcinoma. Preliminary report 92
Activation of the kynurenine pathway predicts poor outcome in patients with clear cell renal cell carcinoma 92
A Troubling Diagnosis of Verrucous Squamous Cell Carcinoma ("the Bad Kind" of Keratosis) and the Need of Clinical and Pathological Correlations: A Review of the Literature with a Case Report. 89
Bladder Metastases from Breast Cancer: Managing the Unexpected. A Systematic Review 89
Surgicel (R) granuloma mimicking ovarian cancer: A case report 87
Development and internal validation of novel nomograms based on benign prostatic obstruction-related parameters to predict the risk of prostate cancer at first prostate biopsy 86
Epigenetic silencing of wnt-inhibitors: activation of a constitutive wnt signalling in oral cancer 85
Voluminous Omental Inflammatory Myofibroblastic Tumor in an Elderly Man: A Case Report and Literature Review 84
Elderly patients are not at higher risk of urinary incontinence after radical prostatectomy 84
One stage surgery for synchronous liver metastasis from a neuroendocrine tumor of the colon. A case report 81
Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization. 80
A case of ovarian psammocarcinoma associated with endometrioid cysts: a morphological and immunohistochemical study. 80
Bladder Metastases from Lung Cancer: Clinical and Pathological Implications: A Systematic Review 80
Hemoperitoneum due to breaking uterine adenosarcoma located in the omentum. Report of a case 80
Altered expression of HER-2 and the mismatch repair genes MLH1 and MSH2 predicts the outcome of T1 high-grade bladder cancer 80
Pentraxin 3: A novel biomarker for predicting progression from prostatic inflammation to prostate cancer 80
Asymptomatic solitary bladder plasmocytoma: A case report and literature review 79
A lycopene and olives vegetation water compound improves lower urinary tract symptoms in men with histologically-proven benign prostatic hyperplasia and inflammation 78
Long-term results of radical surgery and adjuvant radiotherapy in a case of primary malignant fibrous histiocytoma of the kidney 77
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer. 76
Pospho-protein-runx-2 expression is a prognostic marker of metastatic prostate carcinoma. 76
Human epidermal growth factor receptor 2 expression is more important than Bacillus Calmette Guerin treatment in predicting the outcome of T1G3 bladder cancer 74
Role of age in prostate and bladder cancer. A critical overview 74
The impact of age on intravesical instillation of Bacille Calmette-Guerin treatment in patients with high-grade T1 bladder cancer 74
ARE WE DOING OUR BEST TO PREVENT THE (UNEXPECTED) DISAPPOINTING SIDE EFFECTS OF AN OTHERWISE SUCCESSFUL CANCER TREATMENT? 73
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 73
Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction. 72
Can inspection of the mouth help clinicians diagnose Crohn's disease? A review 70
Magnetic resonance imaging of penile paraffinoma: Case report 69
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 69
Daily tadalafil for the chronic phase of stuttering priapism: A case report 68
Detection of novel Human papilloma virus type 82 in laryngeal cancer: case report. 68
Urine TMPRSS2: ERG Fusion Transcript as a Biomarker for Prostate Cancer: Literature Review 66
Cyclooxygenase isozymes in oral squamous cell carcinoma: a real-time RT-PCR study with clinic pathological correlations. 65
An unusual delayed complication of paraffin self-injection for penile girth augmentation. 65
Can Inspection of the Mouth Help Clinicians Diagnose Crohn's Disease? A Review 65
Molecular markers in bladder cancer: Novel research frontiers 65
p-NFkB expression in thyroid cancer. 64
Evolving concepts and use of immunohistochemical biomarkers in flat non-neoplastic urothelial lesions: WHO 2016 classification update with diagnostic algorithm 64
Ectopic manifestation of a cholesterol granuloma in the nasopalatine duct 63
Asymptomatic bladder metastasis from breast cancer. 62
Prospective Validation of Pentraxin-3 as a Novel Serum Biomarker to Predict the Risk of Prostate Cancer in Patients Scheduled for Prostate Biopsy 62
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy 60
Combined perianal-intrarectal (PI) lidocaine-prilocaine (LP) cream and lidocaine-ketorolac gel provide better pain relief than combined PI LP cream and periprostatic nerve block during transrectal prostate biopsy. 59
Noninfiltrative anesthesia for transrectal prostate biopsy: A randomized prospective study comparing lidocaine-prilocaine cream and lidocaine-ketorolac gel 59
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 58
Simultaneous radical nephroureterectomy and transurethral distal ureter balloon occlusion and detachment 58
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 57
Testicular metastasis as the first clinical manifestation of pancreatic adenocarcinoma: A case report 57
Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets 57
Assessing treatment response after intravesical bacillus Calmette-Guerin induction cycle: are routine bladder biopsies necessary? 57
Bladder metastasis from lung adenocarcinoma: a difficult differential diagnosis with primary bladder adenocarcinoma. 55
Foggia Prostate Cancer Risk Calculator 2.0: A Novel Risk Calculator including MRI and Bladder Outlet Obstruction Parameters to Reduce Unnecessary Biopsies 54
Multiple Skeletal Muscle Metastases from Colon Carcinoma Preceded by Paraneoplastic Dermatomyositis 53
Multiparametric magnetic resonance imaging/transrectal ultrasound fusion-guided prostate biopsy: A comparison with systematic transrectal ultrasound-guided prostate biopsy 52
Micropapillary bladder cancer, a variant histology of the elderly 52
Predictive markers in bladder cancer: Do we have molecular markers ready for clinical use? 51
Typing the atypical: Diagnostic issues and predictive markers in suspicious prostate lesions 51
The complex relationship between upper urinary tract and bladder cancer: Clinical and predictive issues 51
Prostate cancer detection rates in different biopsy schemes. Which cores for which patients? 50
Prostatic inflammation is associated with benign prostatic hyperplasia rather than prostate cancer 50
Pilonidal cyst of the penis mimicking carcinoma. 49
Surgicel® granuloma mimicking ovarian cancer: A case report 49
Increased expression of the autocrine motility factor is associated with poor prognosis in patients with clear cell-renal cell carcinoma 49
Modulation of complement activation by pentraxin-3 in prostate cancer 49
Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer 49
Elderly patients and prostate biopsy. How old is too old? 49
The broad landscape of follicular lymphoma: Part I 48
Epidermoid cyst of the coronal sulcus mimicking penile cancer: a case report. 47
One-Day Prostate Cancer Diagnosis: Biparametric Magnetic Resonance Imaging and Digital Pathology by Fluorescence Confocal Microscopy 47
Prostate cancer biomarkers: a practical review based on different clinical scenarios 47
Are Two Meshes Better than One in Sacrocolpopexy for Pelvic Organ Prolapse? Comparison of Single Anterior versus Anterior and Posterior Vaginal Mesh Procedures 45
Impact of time to second transurethral resection on oncological outcomes of patients with high-grade T1 bladder cancer treated with intravesical Bacillus Calmette–Guerin 44
SARS-CoV-2-related lung pathology: macroscopic and histologic features and their clinical implications 44
Osseous metaplasia within a urothelial bladder cancer nodal metastasis: a case report. 43
Distinctive morphological and molecular features of urothelial carcinoma with an inverted growth pattern 43
Bioptic intraprostatic chronic inflammation predicts adverse pathology at radical prostatectomy in patients with low-grade prostate cancer 42
Morphological and Immunohistochemical Biomarkers in Distinguishing Prostate Carcinoma and Urothelial Carcinoma: A Comprehensive Review 41
Urinary tract large cell neuroendocrine carcinoma: Diagnostic, prognostic and therapeutic issues 41
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 41
Does Multiparametric Magnetic Resonance of Prostate Outperform Risk Calculators in Predicting Prostate Cancer in Biopsy Naïve Patients? 39
Molecular markers predicting disease outcome in bladder cancer. Should we shift from the classical cell-cycle regulators to her2 oncogene? 36
Intraoperative Digital Analysis of Ablation Margins (DAAM) by Fluorescent Confocal Microscopy to Improve Partial Prostate Gland Cryoablation Outcomes.  36
Prognostic and therapeutic role of HER2 expression in micropapillary carcinoma of the bladder 35
Benign Lymphoepithelial Cyst of the Parotid Gland: Mind the Underlying Cause 35
Neoadjuvant Chemotherapy Before Radical Cystectomy: Why We Must Adhere? 34
Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study 32
T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic Marker 31
PD-L1 as a prognostic and predictive biomarker in neuroendocrine tumors of the lung: state of the art and future perspectives 28
Are We Ready to Implement Molecular Subtyping of Bladder Cancer in Clinical Practice? Part 2: Subtypes and Divergent Differentiation 27
T-cell prolymphocytic leukemia: Insidious onset followed by aggressive course with cutaneous involvement 27
Totale 6.432
Categoria #
all - tutte 56.957
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.957


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020662 0 0 0 0 138 130 163 12 90 22 94 13
2020/2021611 90 5 74 12 81 12 89 33 97 98 11 9
2021/2022796 58 12 38 12 45 8 91 60 98 149 27 198
2022/20232.989 261 181 146 107 144 229 10 222 1.522 44 55 68
2023/2024811 83 37 36 20 38 273 72 38 10 23 41 140
2024/2025440 151 51 131 62 45 0 0 0 0 0 0 0
Totale 7.592